AstraZeneca

astrazeneca.com · Cambridge, United Kingdom

AstraZeneca is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines, with a primary focus on oncology, cardiovascular, renal and metabolism, and respiratory and immunology diseases. It serves healthcare providers, hospitals, and governments worldwide, generating revenue through the sale of branded pharmaceuticals and biologic therapies. The company also engages in research collaborations and licensing agreements with other life sciences organizations.

Revenue
$1B+
Employees
5,001+
Founded
1999
Headquarters
Cambridge, United Kingdom

AstraZeneca customers on Arbolus

Total customers 14 13 current · 1 former
Reviews growth 9 new reviews since Jun 2026

Customers who reviewed AstraZeneca

Seniority of AstraZeneca customers

Most people who reviewed AstraZeneca hold Director roles (55%), followed by C-Suite (36%) and Manager (9%).

  • Director 55%
  • C-Suite 36%
  • Manager 9%

Customers sample

Not specified Director NPS 10
Other Generalist C-Suite NPS 10 Will renew
Other Analyst Not specified NPS 9

Employer names and spend open once the report publishes.

What 13 Arbolus experts think of AstraZeneca

Overall sentiment: Positive

NPS is consistently high, with a range of 7 to 10 and a concentration of scores in the 8–10 bracket. Renewal intent, when provided, is unanimously positive; users and influencers confirm intent or high likelihood to renew. The vast majority of experts report an implementation stage of more than one year, indicating high stickiness. Key themes are satisfaction with long-term service, minimal churn risk, and broad positive sentiment across clinical and administrative roles.

Tell us when the AstraZeneca report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

38 Net Promoter Score, from 13 scored reviews
  • Promoters 5
  • Passives 8
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 100%
  • Will renew 5
  • Undecided 0
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 2 answers
  • Director 100% 3 answers
  • 8.2/10 Average score from customers who will renew

Top alternatives

Most weighed by AstraZeneca customers

For people who use AstraZeneca

Do you use AstraZeneca at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 13 customers of AstraZeneca have already contributed

Takes a few minutes. Your identity stays anonymous.